Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | SMAD3 | P84022 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29211010 | 0.81 | FTO (0.41) | FTOMEN1KMT2AMAPTHPGD | |
| SCHEMBL3418230 | 0.76 | HPGD (0.45) | FTOMEN1KMT2AMAPTHPGD | |
| SCHEMBL1682554 | 0.75 | SMAD3 (0.40) | MEN1KMT2AMAPTHPGDSMAD3 | |
| SCHEMBL93663 | 0.73 | MEN1 (0.31) | FTOMEN1KMT2AMAPTHPGD | |
| SCHEMBL3699713 | 0.73 | ALDH1A1 (0.45) | FTOMEN1KMT2AMAPTHPGD | |
| SCHEMBL6026564 | 0.73 | SMAD3 (0.41) | MEN1KMT2AMAPTHPGDHTT | |
| SCHEMBL29831001 | 0.73 | GNG2 (0.40) | FTOMEN1KMT2AMAPTHPGD | |
| SCHEMBL345532 | 0.73 | GNG2 (0.40) | FTOMEN1KMT2AMAPTHPGD | |
| SCHEMBL27987131 | 0.71 | FTO (0.59) | FTOMEN1KMT2AMAPTHPGD | |
| SCHEMBL29353753 | 0.71 | MEN1 (0.39) | MEN1KMT2AMAPTHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114573692-B | Immunoassay and antibodies for detection of chromogranin A | 塞尚公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20230399455-A1 | BIO-FUNCTIONALIZATION OF WATER-SOLUBLE POLY(PHENYLENE EHTYLENE)S | UNIV TEXAS (US) | 2023-12-14 | — | — | US | disclosed |
| CN-116819066-A | Liver cancer microenvironment detection kit | 复旦大学附属中山医院 | 2023-09-29 | — | — | CN | disclosed |
| CN-116685329-A | Nucleic acid constructs and their use for the treatment of spinal muscular atrophy | 杭州嘉因生物科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116234553-A | Methods of treating systemic lupus erythematosus and use of biomarkers as predictors of clinical sensitivity to therapy | 新基公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-116157666-A | Electric field assisted sample preparation | 安捷伦科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116096884-A | Isothermal methods, compositions, kits and systems for detecting nucleic acids | 哈佛大学校长及研究员协会 | 2023-05-09 | — | — | CN | disclosed |
| CN-115280148-A | Method for determining peptidylglycine alpha-amidating monooxygenase (PAM) and use thereof for diagnostic purposes | PAM治疗诊断有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-115243709-A | Use of peptidylglycine alpha-amidating monooxygenase (PAM) for therapeutic purposes | PAM治疗诊断有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-115003827-A | Analyte detection | 密歇根大学董事会 | 2022-09-02 | — | — | CN | disclosed |
| CN-114196746-A | Detection of nucleic acids | 密歇根大学董事会 | 2022-03-18 | — | — | CN | disclosed |
| CN-105917232-B | Method for selective determination of placental growth factor 2 | 塞尚公司 | 2020-10-16 | — | — | CN | disclosed |
| CN-111542755-A | Selenoprotein P for prediction of first cardiovascular events | 思芬构技术有限公司 | 2020-08-14 | — | — | CN | disclosed |
| CN-111295588-A | Method for determining the selectivity of a test compound | 分子医学研究中心责任有限公司 | 2020-06-16 | — | — | CN | disclosed |
| CN-110730826-A | Analyte detection | 密歇根大学董事会 | 2020-01-24 | — | — | CN | disclosed |
| WO-2005049849-A2 | FLUORESCENCE QUENCHING AZO DYES, THEIR METHODS OF PREPARATION AND USE | INTEGRATED DNA TECHNOLOGIES, INC. (US) | 2005-06-02 | — | — | WO | disclosed |
| WO-2002061130-A2 | METHODS AND REAGENTS FOR ANALYSIS OF RNA STRUCTURE AND FUNCTION | TRANSGENOMIC, INC. (US) | 2002-08-08 | — | — | WO | disclosed |
| WO-1998014612-A9 | CYANINE DYES WITH HIGH-ABSORBANCE CROSS SECTION AS DONOR CHROMOPHORES IN ENERGY TRANSFER LABELS | — | 1998-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399455-A1 | BIO-FUNCTIONALIZATION OF WATER-SOLUBLE POLY(PHENYLENE EHTYLENE)S | PGLS, EPCAM, CD69 | FTO 867/4885MEN1 3472/4885KMT2A 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.